Clover Health Investments, Corp. (“Clover” or “the Company”), which operates next-generation Medicare Advantage plans, has entered into a definitive agreement to become publicly traded via a merger with Social Capital Hedosophia Holdings Corp. III. The SPAC is led by early Facebook executive Chamath Palihapitiya.
Related Posts
Zaoui Brothers Take U.K. Drugmaker Startup Public Via SPAC
BenevolentAI will combine with Odyssey Acquisition SA, a 300 million-euro blank check company that the Zaoui brothers listed on Euronext Amsterdam.
Gores Again Encourages Shareholders to Vote for Luminar Merger
The SPAC's proposed merger with Luminar was announced last month.
Foley Trasimene to Merge With Alight in $3B Deal
The transaction reflects an implied pro-forma enterprise value for Alight of approximately $7.3 billion.
NewAmsterdam Pharma and Frazier Lifesciences Acquisition Merging in $326M Deal
The deal is supported by a $235 million PIPE.